|
Insider Trading: NEUROCRINE BIOSCIENCES INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NEUROCRINE BIOSCIENCES INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of NEUROCRINE BIOSCIENCES INC since year 2005. Table 2 shows the detailed insider transactions of NEUROCRINE BIOSCIENCES INC since 2005.
The reporting company's ticker symbol is NBIX.
The reporting company's CIK number is 914475.
The total value of stock buying since 2005 is $7,768,285.
The total value of stock sales is $8,618,316.
The total value of stock exercises is $465,296.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at NEUROCRINE BIOSCIENCES INC (NBIX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at NEUROCRINE BIOSCIENCES INC (NBIX) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for NEUROCRINE BIOSCIENCES INC (NBIX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 156,800 | 662,297 | 0 | 0 | 0 | 0 |
| 2008-05 | 179,700 | 834,678 | 6,485 | 32,749 | 0 | 0 |
| 2008-03 | 890,700 | 4,399,532 | 0 | 0 | 0 | 0 |
| 2008-02 | 384,200 | 1,871,778 | 35,344 | 178,397 | 0 | 0 |
| 2007-04 | 0 | 0 | 0 | 0 | 63,091 | 465,296 |
| 2006-05 | 0 | 0 | 115,481 | 2,307,021 | 0 | 0 |
| 2006-03 | 0 | 0 | 10,000 | 700,133 | 0 | 0 |
| 2005-12 | 0 | 0 | 18,000 | 1,148,547 | 0 | 0 |
| 2005-11 | 0 | 0 | 40,000 | 2,314,219 | 0 | 0 |
| 2005-10 | 0 | 0 | 10,000 | 515,000 | 0 | 0 |
| 2005-09 | 0 | 0 | 20,000 | 990,000 | 0 | 0 |
| 2005-08 | 0 | 0 | 5,000 | 233,750 | 0 | 0 |
| 2005-06 | 0 | 0 | 5,000 | 198,500 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for NEUROCRINE BIOSCIENCES INC (NBIX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-08 | Bvf Inc/il (Other) | Purchase | 3,400 | 4.25 | 14,450 |
| 2008-07-07 | Bvf Inc/il (Other) | Purchase | 115,700 | 4.24 | 490,718 |
| 2008-07-03 | Bvf Inc/il (Other) | Purchase | 11,100 | 4.15 | 46,032 |
| 2008-07-02 | Bvf Inc/il (Other) | Purchase | 26,600 | 4.18 | 111,097 |
| 2008-05-28 | Bvf Inc/il (Other) | Purchase | 22,100 | 4.72 | 104,312 |
| 2008-05-27 | Bvf Inc/il (Other) | Purchase | 5,000 | 4.71 | 23,555 |
| 2008-05-16 | Bvf Inc/il (Other) | Purchase | 26,300 | 4.65 | 122,358 |
| 2008-05-15 | Bvf Inc/il (Other) | Purchase | 126,300 | 4.63 | 584,453 |
| 2008-05-13 | Grigoriadis Dimitri E. (Vice President, Research) | Sale | 6,485 | 5.05 | 32,749 |
| 2008-03-20 | Bvf Inc/il (Other) | Purchase | 43,600 | 5.00 | 218,000 |
| 2008-03-18 | Bvf Inc/il (Other) | Purchase | 153,000 | 4.96 | 759,109 |
| 2008-03-12 | Bvf Inc/il (Other) | Purchase | 14,800 | 5.00 | 74,000 |
| 2008-03-11 | Bvf Inc/il (Other) | Purchase | 141,800 | 4.90 | 694,266 |
| 2008-03-10 | Bvf Inc/il (Other) | Purchase | 225,000 | 4.89 | 1,100,655 |
| 2008-03-07 | Bvf Inc/il (Other) | Purchase | 104,600 | 4.99 | 521,912 |
| 2008-03-06 | Bvf Inc/il (Other) | Purchase | 86,700 | 5.00 | 433,161 |
| 2008-03-04 | Bvf Inc/il (Other) | Purchase | 23,200 | 4.97 | 115,417 |
| 2008-03-03 | Bvf Inc/il (Other) | Purchase | 98,000 | 4.93 | 483,012 |
| 2008-02-29 | Bvf Inc/il (Other) | Purchase | 47,400 | 4.99 | 236,706 |
| 2008-02-28 | Bvf Inc/il (Other) | Purchase | 23,000 | 5.00 | 115,000 |
| 2008-02-26 | Bvf Inc/il (Other) | Purchase | 20,800 | 5.00 | 103,975 |
| 2008-02-25 | Bvf Inc/il (Other) | Purchase | 108,000 | 4.96 | 535,204 |
| 2008-02-22 | Bvf Inc/il (Other) | Purchase | 79,000 | 4.84 | 382,312 |
| 2008-02-21 | Bvf Inc/il (Other) | Purchase | 106,000 | 4.70 | 498,581 |
| 2008-02-12 | Coughlin Timothy P (VP and Chief Financial Officer) | Sale | 7,857 | 5.03 | 39,526 |
| 2008-02-12 | Ranieri Richard J (Sr. VP, Human Resources) | Sale | 9,666 | 5.04 | 48,704 |
| 2008-02-12 | Gorman Kevin Charles (President & CEO) | Sale | 8,230 | 5.03 | 41,373 |
| 2008-02-12 | Valeur Jensen Margaret E (EVP and General Counsel) | Sale | 7,663 | 5.03 | 38,566 |
| 2008-02-05 | Grigoriadis Dimitri E. (Vice President, Research) | Sale | 1,206 | 5.31 | 6,398 |
| 2008-02-05 | Bozigian Haig P. (Sr Vice President, Development) | Sale | 722 | 5.31 | 3,830 |
| 2007-04-23 | Lyons Gary A (President and CEO) | Option Exercise | 63,091 | 7.38 | 465,296 |
| 2006-05-17 | Hawran Paul W (Executive VP and CFO) | Sale | 115,481 | 19.98 | 2,307,021 |
| 2006-03-03 | Vale Wylie W (Director) | Sale | 10,000 | 70.01 | 700,133 |
| 2005-12-21 | Vale Wylie W (Director) | Sale | 10,000 | 65.03 | 650,300 |
| 2005-12-08 | Gorman Kevin Charles (Sr VP, Business Dev.) | Sale | 3,000 | 62.85 | 188,547 |
| 2005-12-05 | Lyons Gary A (President and CEO) | Sale | 5,000 | 61.94 | 309,700 |
| 2005-11-22 | Lyons Gary A (President and CEO) | Sale | 5,000 | 61.77 | 308,840 |
| 2005-11-18 | Vale Wylie W (Director) | Sale | 10,000 | 60.04 | 600,410 |
| 2005-11-18 | Lyons Gary A (President and CEO) | Sale | 5,000 | 59.71 | 298,550 |
| 2005-11-03 | Lyons Gary A (President and CEO) | Sale | 10,000 | 55.64 | 556,370 |
| 2005-11-02 | Vale Wylie W (Director) | Sale | 5,021 | 55.00 | 276,155 |
| 2005-11-01 | Vale Wylie W (Director) | Sale | 4,979 | 55.01 | 273,894 |
| 2005-10-28 | Lyons Gary A (President and CEO) | Sale | 10,000 | 51.50 | 515,000 |
| 2005-09-07 | Vale Wylie W (Director) | Sale | 10,000 | 50.00 | 500,000 |
| 2005-09-07 | Lyons Gary A (President and CEO) | Sale | 10,000 | 49.00 | 490,000 |
| 2005-08-18 | Lyons Gary A (President and CEO) | Sale | 5,000 | 46.75 | 233,750 |
| 2005-06-15 | Lyons Gary A (President and CEO) | Sale | 5,000 | 39.70 | 198,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of NEUROCRINE BIOSCIENCES INC (symbol NBIX,
CIK number 914475) see
the Securities and Exchange Commission (SEC) website.
|
|
